Equities

Inotiv Inc

Inotiv Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)3.00
  • Today's Change0.37 / 14.07%
  • Shares traded949.83k
  • 1 Year change+63.93%
  • Beta3.5173
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Inotiv Inc grew revenues 4.52% from 547.66m to 572.43m while net income improved from a loss of 337.02m to a smaller loss of 105.14m.
Gross margin24.93%
Net profit margin-19.70%
Operating margin-14.13%
Return on assets-12.11%
Return on equity-43.31%
Return on investment-19.28%
More ▼

Cash flow in USDView more

In 2023, Inotiv Inc increased its cash reserves by 87.00%, or 16.51m. The company earned 27.88m from its operations for a Cash Flow Margin of 4.87%. In addition the company generated 15.87m cash from financing while 28.76m was spent on investing.
Cash flow per share-1.61
Price/Cash flow per share--
Book value per share7.00
Tangible book value per share-7.49
More ▼

Balance sheet in USDView more

Inotiv Inc has a Debt to Total Capital ratio of 67.74%, a lower figure than the previous year's 134.67%.
Current ratio0.3077
Quick ratio0.2279
Total debt/total equity2.10
Total debt/total capital0.6774
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.